These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9404975)

  • 21. Bleeding in liver surgery: prevention and treatment.
    Alkozai EM; Lisman T; Porte RJ
    Clin Liver Dis; 2009 Feb; 13(1):145-154. PubMed ID: 19150318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis.
    Abrishami A; Chung F; Wong J
    Can J Anaesth; 2009 Mar; 56(3):202-12. PubMed ID: 19247741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
    Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifibrinolytic therapy: treat whom and with what?
    Horrow JC
    J Clin Anesth; 1995 Dec; 7(8):690. PubMed ID: 8747571
    [No Abstract]   [Full Text] [Related]  

  • 26. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group.
    Porte RJ; Molenaar IQ; Begliomini B; Groenland TH; Januszkiewicz A; Lindgren L; Palareti G; Hermans J; Terpstra OT
    Lancet; 2000 Apr; 355(9212):1303-9. PubMed ID: 10776742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
    Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should aprotinin be reconsidered for use in pediatric surgery?
    Goobie S
    Paediatr Anaesth; 2014 Feb; 24(2):137-40. PubMed ID: 24387146
    [No Abstract]   [Full Text] [Related]  

  • 29. Aprotinin--are there lessons learned?
    Ferguson TB
    JAMA; 2007 Feb; 297(5):527-9. PubMed ID: 17284704
    [No Abstract]   [Full Text] [Related]  

  • 30. Heparin and antifibrinolytic agents during experimental hepatectomy and liver transplantation.
    Moriau M; Kestens PJ; Masure R
    Pathol Eur; 1969; 4(2):172-82. PubMed ID: 4896202
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of antifibrinolytics in orthotopic liver transplantation.
    Kufner RP
    Transplant Proc; 2000 May; 32(3):636-7. PubMed ID: 10812148
    [No Abstract]   [Full Text] [Related]  

  • 32. Aprotinin: safe and effective in all patients undergoing orthotopic liver transplantation?
    Porte RJ; Slooff MJ
    Liver Transpl; 2001 Sep; 7(9):808-10. PubMed ID: 11552216
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effects of aprotinin. Blood loss and coagulation parameters in orthotopic liver transplantation: A clinical-experimental, prospective and randomized double-blind study].
    Kratzer MA; Azad SC; Groh J; Welte M; Haller M; Pratschke E
    Anaesthesist; 1997 Apr; 46(4):294-302. PubMed ID: 9229983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients.
    Bernet F; Carrel T; Marbet G; Skarvan K; Stulz P
    J Card Surg; 1999; 14(2):92-7. PubMed ID: 10709819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Zufferey P; Merquiol F; Laporte S; Decousus H; Mismetti P; Auboyer C; Samama CM; Molliex S
    Anesthesiology; 2006 Nov; 105(5):1034-46. PubMed ID: 17065899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifibrinolytic agents and desmopressin as hemostatic agents in cardiac surgery.
    Erstad BL
    Ann Pharmacother; 2001 Sep; 35(9):1075-84. PubMed ID: 11573859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization.
    Mongan PD; Brown RS; Thwaites BK
    Anesth Analg; 1998 Aug; 87(2):258-65. PubMed ID: 9706913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
    Li G; Sun TW; Luo G; Zhang C
    Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aprotinin and hemostasis.
    Schisano G; Nina P
    J Neurosurg; 2005 Apr; 102(4):757-8; author reply 758. PubMed ID: 15871522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.